Are Options Traders Betting on a Big Move in Medpace Stock?
Is Medpace (MEDP) Stock Outpacing Its Medical Peers This Year?
3 Reasons Why Growth Investors Shouldn't Overlook Medpace (MEDP)
If You Invested $1000 in Medpace a Decade Ago, This is How Much It'd Be Worth Now
Did Earnings Beat Just Shift Medpace Holdings (MEDP) Investment Narrative?
CON vs. MEDP: Which Stock Is the Better Value Option?
Medpace (MEDP) is a Great Momentum Stock: Should You Buy?
Is Medpace (MEDP) a Solid Growth Stock? 3 Reasons to Think "Yes"
All You Need to Know About Medpace (MEDP) Rating Upgrade to Buy
BMO Capital Maintains Market Perform on Medpace Holdings, Raises Price Target to $670
Medpace: Downgrade 'Hold' Revenue Growth Guidance Change And Slightly Lower Backlog Conversion Rate
MEDP Q3 deep dive: bookings strength drives growth, margin expansion continues
UBS Maintains Neutral on Medpace Holdings, Raises Price Target to $700
Truist Securities Maintains Hold on Medpace Holdings, Raises Price Target to $633
5 revealing analyst questions from Medpace’s Q3 earnings call
Barclays Maintains Equal-Weight on Medpace Holdings, Raises Price Target to $675
TD Cowen Maintains Hold on Medpace Holdings, Raises Price Target to $673
Does Medpace Holdings (MEDP) Leave Any Room For Cash Flow Upside?
Medpace Holdings (MEDP) Beat Q3 Estimates, Is It Still 24% Overvalued?
Medpace Slumps On Solid Report — Where Are The 'Holes?'
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.